Comparison of Outcome in Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)

American Journal of Cardiology

Volumn 100, Issue 2, 2007, Pages 190-195

  Abbott, J Dawn ^a   Ahmed, Hanna N ^a   Vlachos, Helen A ^b   Selzer, Faith ^b   Williams, David O ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENO[2,3 B]PYRIDINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CANCER; CARDIOGENIC SHOCK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STROKE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 34447251596     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.02.083     Document Type: Article

References (27)

1. Dauerman H.L., Yarzebski J., Gore J.M., Lessard D., and Goldberg R.J. Use of the invasive management strategy for patients with non-Q-wave myocardial infarction: an observational database report from the Worcester Heart Attack Study. Am Heart J 143 (2002) 1033-1039
2. Rogers W.J., Canto J.G., Lambrew C.T., Tiefenbrunn A.J., Kinkaid B., Shoultz D.A., Frederick P.D., and Every N. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 36 (2000) 2056-2063
3. Nicod P., Gilpin E., Dittrich H., Polikar R., Hjalmarson A., Blacky A.R., Henning H., and Ross Jr. J. Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation 79 (1989) 528-536
4. Goodman S.G., Langer A., Ross A.M., Wildermann N.M., Barbagelata A., Sgarbossa E.B., Wagner G.S., Granger C.B., Califf R.M., Topol E.J., Simoons M.L., Armstrong P.W., and GUSTO-I Angiographic Investigators. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. Circulation 97 (1998) 444-450
5. Berger C.J., Murabito J.M., Evans J.C., Anderson K.M., and Levy D. Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA 268 (1992) 1545-1551
6. Phibbs B., Marcus F., Marriott H.J., Moss A., and Spodick D.H. Q-wave versus non-Q wave myocardial infarction: a meaningless distinction. J Am Coll Cardiol 33 (1999) 576-582
7. Furman M.I., Dauerman H.L., Goldberg R.J., Yarzebski J., Lessard D., and Gore J.M. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 37 (2001) 1571-1580
8. Welty F.K., Mittleman M.A., Lewis S.M., Healy R.W., Shubrooks Jr. S.J., and Muller J.E. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol 76 (1995) 431-435
9. Stone P.H., Raabe D.S., Jaffe A.S., Gustafson N., Muller J.E., Turi Z.G., Rutherford J.D., Poole W.K., Passamani E., Willerson J.T., et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol 11 (1988) 453-463
10. Ogawa H., Hiramori K., Haze K., Saito M., Sumiyoshi T., Fukami K., Goto Y., and Ikeda M. Comparison of clinical features of non-Q wave and Q wave myocardial infarction. Am Heart J 111 (1986) 513-518
11. Krone R.J., Friedman E., Thanavaro S., Miller J.P., Kleiger R.E., and Oliver G.C. Long-term prognosis after first Q-wave (transmural) or non-Q-wave (nontransmural) myocardial infarction: analysis of 593 patients. Am J Cardiol 52 (1983) 234-239
12. Holmes Jr. D.R., Bates E.R., Kleiman N.S., Sadowski Z., Horgan J.H., Morris D.C., Califf R.M., Berger P.B., Topol E.J., and The GUSTO-I Investigators. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 26 (1995) 668-674
13. Hochman J.S., Sleeper L.A., Webb J.G., Sanborn T.A., White H.D., Talley J.D., Buller C.E., Jacobs A.K., Slater J.N., Col J., McKinlay S.M., LeJemtel T.H., and SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 341 (1999) 625-634
14. Ferguson J.J., Califf R.M., Antman E.M., Cohen M., Grines C.L., Goodman S., Kereiakes D.J., Langer A., Mahaffey K.W., Nessel C.C., et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 292 (2004) 45-54
15. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367 (2006) 569-578
16. Dauerman H.L., Goldberg R.J., White K., Gore J.M., Sadiq I., Gurfinkel E., Budaj A., Lopez de Sa E., Lopez-Sendon J., and Global Registry of Acute Coronary Events GI. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 90 (2002) 838-842
17. Yamaguchi J., Kasanuki H., Ishii Y., Yagi M., Ogawa H., Fujii S.Y., Koganei H., Okada H., Kimura H., Horie T., et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 93 (2004) 1526-1528
18. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345 (1995) 669-685
19. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343 (1994) 1115-1122
20. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2 (1986) 57-66
21. Benhorin J., Moss A.J., Oakes D., Marcus F., Greenberg H., Dwyer Jr. E.M., Algeo S., Hahn E., and The Multicenter Diltiazem Post-Infarction Research Group. The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q wave location. J Am Coll Cardiol 15 (1990) 1201-1207
22. Kerensky R.A., Wade M., Deedwania P., Boden W.E., Pepine C.J., and Veterans Affairs Non QWISi-HTI. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 39 (2002) 1456-1463
23. Watkins S., Thiemann D., Coresh J., Powe N., Folsom A.R., and Rosamond W. Fourteen-year (1987 to 2000) trends in the attack rates of, therapy for, and mortality from non-ST-elevation acute coronary syndromes in four United States communities. Am J Cardiol 96 (2005) 1349-1355
24. de Winter R.J., Windhausen F., Cornel J.H., Dunselman P.H., Janus C.L., Bendermacher P.E., Michels H.R., Sanders G.T., Tijssen J.G., Verheugt F.W., and Invasive versus Conservative Treatment in Unstable Coronary Syndromes I. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353 (2005) 1095-1104
25. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., Braunwald E., and Investigators TTiMI. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887
26. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 354 (1999) 708-715
27. Antman E.M., Cohen M., Bernink P.J., McCabe C.H., Horacek T., Papuchis G., Mautner B., Corbalan R., Radley D., and Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842